Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Phase 2 trial of an investigational agent for bipolar depression with surrogate mood and safety endpoints; study is actively recruiting with no results posted.
This is an active Phase 2 feasibility and safety study with no results posted; it measures acceptability and tolerability in a small planned cohort (n=10) with suicidality as a secondary focus, not a completed trial with efficacy data.